WHO OWNS YOUR DNA NOW? Regeneron Buys 23andMe in $256 Million Deal Amid Mounting Fears Over Genetic Privacy Bioethics
GOVERNING THE MACHINE: Inside the FTC’s Split on AI Regulation, Surveillance Capitalism, and Data Power Artificial Intelligence Regulation
GENETIC BETRAYAL: 23andMe Files for Bankruptcy — Millions of DNA Profiles Now at Risk Biotech Betrayals